In this episode of Listening In (With Permission), Andréa Caballero of Catalyst for Payment Reform sits down with Caroline McLeod, a practicing dental clinician and leader at CareQuest Institute for
In this episode of Listening In (With Permission), Andréa connects with Kristof Stremikis, Director, Market Analysis and Insights at the California Healthcare Foundation, for a candid exploration of Medicaid’s evolving
In this episode of Listening In (With Permission), Ryan Olmstead sits down with Mike Hanlon, founder and CEO of Abett, to unpack some of the boldest ideas in health benefits
This podcast is part of The Healthcare Highway, a limited series from CPR featuring conversations with public and commercial healthcare purchasers—and the advocates working alongside them—across the country. In this
This podcast is sponsored by AbbVie. Join CPR and AbbVie on June 10 for the webinar, Understanding the Impact of Mental Health Disorders on the Workplace. Tune in to explore
Kendra Gipson, Director, Vendor Services & Contracts for the State of Tennessee, speaks with Ryan Olmstead to discuss key healthcare reforms in Tennessee, particularly around pharmacy benefit managers (PBM) and
Andréa Caballero, Vice President of Policy at Catalyst for Payment Reform, calls Patricia Kelmar, Senior Health Care Campaigns Director for U.S. PIRG to discuss one of the most pressing issues
Andréa Caballero, Vice President of Policy at Catalyst for Payment Reform, calls Katie Gudiksen, Executive Editor at The Source on Healthcare Price and Competition, and Brent Fulton, Associate Research Professor
In this inaugural episode of the Healthcare Highway, CPR’s limited podcast series, Ryan Olmstead sits down with Misha Sharp, the Assistant Director of Policy at the 32BJ Health Fund, to
2024 was a difficult year for our CPR community. In May our beloved founding executive director, Suzanne Delbanco, lost her four-year battle with cancer. Her family, the CPR staff, and
In the latest episode of Listening In (With Permission), we dive deep into the challenges and potential solutions around high healthcare costs that employers face in states like Florida, Michigan,
On this episode Ryan calls Glen Tullman, CEO of Transcarent, to discuss the untapped power of generative AI in revolutionizing healthcare accessibility and affordability. Glen describes the concept of “wayfinding”,
In this episode, Ryan sits down with Paul Grady, Principal at Alera Group to discuss the critical role of purchaser activation in mitigating rising costs in healthcare and improving outcomes.
Tune into our latest episode of Listening In (With Permission) as Ashok Subramanian, CEO and founder of Centivo, and Ryan Olmstead dive deep into the critical issues of healthcare affordability
In this episode of Listening In (With Permission), Ryan calls Chris Chan, Chief Value Officer of finHealth, to discuss the pitfalls many self-insured employers face related to their claims review
In this episode of Listening In (With Permission) Dr. Matthew Resnick, Chief Medical Officer at Embold Health, discusses with Ryan the evolution of quality measurement and improvement in healthcare, emphasizing
In this podcast episode Dayne and Tim Huke, Chief Growth Officer for Cedar Gate Technologies, explore firsthand the core of CPR’s latest case study, Unlocking Value: Diabetes Care Management Vendors’
$935 billion. It’s hard to imagine what that number really means. It’s approximately the amount the United States spends on Medicare, it exceeds our national military spending, and it’s more than what
32BJ Health Fund | New York’s pricey hospitals draw pushback from labor Aon | U.S. Employers Eye Provider Networks Amid Looming Medical Cost Pressures, Aon Reports CalPERS | CA VBID Program Boosted Primary
At CPR, we have a saying: if you don’t have a REF, you can’t trust the scoreboard. That’s why CPR created “Reform Evaluation Frameworks,” or – affectionately – REFs.
REFs are program evaluation tools that compel plan administrators and point solution vendors to use a standardized methodology and standardized set of performance indicators to measure cost savings, clinical quality and utilization.
